The brain implant is said to be the first of its kind that targets chronic pain, which usually arises without a known trigger.
Biocept has initiated the full commercial launch of CNSide, its cerebrospinal fluid (CSF) assay that helps identify and manage the treatment of metastatic cancers involving the central nervous system (CNS).
The US Food and Drug Administration (FDA) has approved Cerus Endovascular’s investigational device exemption (IDE) application to carry out a trial of its Contour Neurovascular System in the country.
Scientists at the Institute of Bioelectronic Medicine at The Feinstein Institutes for Medical Research have developed a long-term nerve implant model for bioelectronic medicine research.
Nēsos has developed an earbud designed to deliver electrical field therapy to help treat inflammatory conditions like arthritis and migraines. Natalie Healey takes a closer look at the emerging technology and speaks to co-founder Konstantinos...
The US Food and Drug Administration (FDA) has authorised the marketing of Helius Medical’s Portable Neuromodulation Stimulator (PoNS) as a short-term treatment for adults with gait deficit from mild to moderate multiple sclerosis (MS).